euro adhoc: Sartorius AG
Mergers - Acquisitions - Takeovers
AMF approves
terms of the mandatory offer of Sartorius AG relating to the shares in Sartorius
Stedim Biotech S.A.
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement.
11.07.2007
Today the French financial market authority Autorité des Marchés Financiers (AMF) has published its approval of the terms of the mandatory offer by Sartorius AG to the shareholders of Sartorius Stedim Biotech S.A. (former name: Stedim S.A.) to acquire their shares at the price of 43 Euro per share. The offer has been filed with the AMF on June 29, 2007. The offer will be open from July 13, 2007 until July 26, 2007. The execution and settlement of the offer marks a further essential step of the entire transaction combining the biotechnology division of Sartorius with the former Stedim S.A. in the course of which Sartorius AG has already acquired the majority of shares in the combined entity. Details regarding the terms of the offer may be derived from the offer document which is available on the website of Sartorius AG under www.sartorius.de.
end of announcement euro adhoc 11.07.2007 13:06:56
Further inquiry note:
Andreas Wiederhold
Treasury & Investor Relations
Telefon: +49 (0)551 308-1668
E-Mail: andreas.wiederhold@sartorius.com
Branche: Biotechnology
ISIN: DE0007165607
WKN: 716560
Index: CDAX, Prime All Share, Technologie All Share
Börsen: Börse Frankfurt / official dealing/prime standard
Börse Berlin / free trade
Börse Hamburg / free trade
Börse Stuttgart / free trade
Börse Düsseldorf / free trade
Börse München / free trade
Börse Hannover / official dealing